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Organic Electronic Materials offer an untapped potential for novel tools for low-invasive 38 
electrophysiological recording and stimulation devices. Such materials combine 39 
semiconducting properties with tailored surface chemistry, elastic mechanical properties and 40 
chemical stability in water. In this work, we investigated solution processed Electrolyte Gated 41 
Organic Field Effect Transistors (EGOFETs) based on a small molecule semiconductor. We 42 
demonstrate that EGOFETs based on a blend of soluble organic semiconductor 2,8-Difluoro-43 
5,11-bis(triethylsilylethynyl)anthradithiophene (diF-TES-ADT) combined with an insulating 44 
polymer show excellent sensitivity and long-term recording under electrophysiological 45 
applications. Our devices can stably record the extracellular potential of human pluripotent 46 
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stem cell derived cardiomyocyte cells (hPSCs-CMs) for several weeks. In addition, 1 
cytotoxicity tests of pharmaceutical drugs, such as Norepinephrine and Verapamil was 2 
achieved with excellent sensitivity. This work demonstrates that organic transistors based on 3 
organic blends are excellent bioelectronics transducer for extracellular electrical recording of 4 
excitable cells and tissues thus providing a valid alternative to electrochemical transistors. 5 
Keywords  6 
Bioelectronics, Organic field effect transistors, Organic electronics, Cardiac cells, Organic 7 
semiconducting blend 8 
1. Introduction 9 
Measuring the extracellular potential of electrically active cells and tissues in a non-invasive 10 
manner is of great interest for developing implantable devices, neuroprothesis (Maya-11 
Vetencourt et al., 2017), brain-computer interfaces (Van De Burgt et al., 2018), artificial 12 
synapstors (Desbief et al., 2016, 2015) and in vitro drug screening or cytotoxicity tests. The 13 
electrical activity of an organ, tissue or cell gives relevant information about its functionality 14 
or dysfunctionality, and it can also be used to monitor its functional response to pharmaceutical 15 
drugs. Non-invasive recording can be achieved by placing an electrode or a device such as a 16 
transistor at the vicinity of the organ/tissue or a cell. When using electrodes, such as the 17 
traditional Microelectrode Array Systems (MEAs), the quality of the electrical measurement 18 
depends on the interface of the electrode with the tissue or cell.  Low impedance electrodes are 19 
desirable for high quality recording with MEAs and this can be achieved by increasing the area 20 
of the recording electrode thus having the expense of spatial resolution. Alternatively the 21 
impedance can be minimized in MEAs by coating the microelectrodes with organic conducting 22 
polymers (Inacio et al., 2017; Khodagholy et al., 2011; Sessolo et al., 2013) or nanostructured 23 
metallic coatings. Currently available methods in the market also include patch clamp that 24 
employs a pipette tip sealed to the cell membrane that can measure the potential between the 25 
membrane and the electrode which is then amplified externally. Although this technique is 26 
useful to get information at the single cell level, it is labour intensive and invasive as it often 27 
leads to cell death due to the rupture of the cell membrane. Another method to measure 28 
extracellular potential variations is the light-addressable potentiometric sensor (LAPS) whose 29 
detection is based on the coupling of  photocurrents to ionic current fluctuations produced by 30 
bioelectric activity of cells (Liu et al., 2007). Field Effect Transistor-based platforms, on the 31 
other hand, represent an excellent alternative due to their intrinsic signal amplification and 32 
scaling down possibilities (Ingebrandt et al., 2001; Khodagholy et al., 2013). Apart from the 33 
device layout, the nature of the interface between the material and the biological system seems 34 
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to be pivotal for the conversion of biological signals, characterized by an ionic nature, into 1 
electronic ones, which rules the mechanism of transduction. There have been many reports in 2 
the field of bioelectronics where biosensors, including transistors are based on different types 3 
of materials such as inorganic or organic materials, 2D material such as graphene or nanowire 4 
transistors (Hess et al., 2011; Zhang and Lieber, 2016). While on the one hand inorganic-based 5 
transistors offer advanced signal amplification due to their superior electrical performance as 6 
compared to organic transistors, and nanowire FETs  offer better sensitivity and the possibility 7 
to scale down the device, on the other hand, their mechanical properties, instability when 8 
operated in direct contact with water electrochemical environments and the difficulty in 9 
chemical modification and fabrication of inorganic devices constitute serious drawbacks. 10 
 11 
To address these issues, organic bioelectronic devices have come into the picture. The main 12 
advantage of using organic transistors is the mechanical property, surface chemistry and 13 
morphology of organic materials can be tuned ad hoc in order to reduce invasiveness on the 14 
biological tissues (Rivnay et al., 2014; Simon et al., 2016). In addition, organic devices can 15 
easily be processed using solution processing techniques avoiding complex fabrication 16 
processes and offering the possibility to work on a variety of substrates, such as flexible or 17 
resorbable substrates (Campana et al., 2014). Organic based transistors have been employed 18 
for extracellular recording by exploiting the electrolyte as a gate of the transistor. Amongst 19 
them, Organic Electrochemical Transistor OECTs (Rivnay et al., 2018) and Electrolyte Gated 20 
Organic Field Effect Transistors EGOFETs (T. Cramer et al., 2013; Tobias Cramer et al., 2013) 21 
are the most documented devices. These devices differ among them basically on the nature of 22 
the active material employed. Commonly used material for OECTs is the conducting polymer 23 
poly(3,4-ethylenedioxythiophene) doped with poly(styrene sulfonate) (PEDOT:PSS) which 24 
works in depletion mode. The functionality of OECTs is governed by injection of cations 25 
(depletion mode) or anions (accumulation mode) from the electrolyte that results in the change 26 
of the doping state of the material thus modulating the bulk conductivity of the organic 27 
semiconductor channel. Due to the coupling between ionic and electronic charges within the 28 
entire volume of the channel, OECTs normally have a higher transconductance compared to 29 
EGOFETs, but at the expense of higher current densities and power consumption during 30 
operation. OECTs have a response time which are relatively slow due to ion diffusion in the 31 
bulk material. EGOFETs on the other hand, are considered to be impermeable to ions and their 32 
functionality is governed by the formation of the electrical double layer at the interface between 33 
the electrolyte and the semiconductor (Fahlman et al., 2019). Although at amorphous regions 34 
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of the organic semiconductor ion penetration cannot be completely excluded, (Giridharagopal 1 
et al., 2017) a high crystalline film normally ensures the electrostatic accumulation of charge 2 
carriers due to the formation of electrical double layer at the electrolyte/semiconductor 3 
interface. 4 
Here, we show that the recently proposed solution processed EGOFETs consisting of an 5 
organic blend of the bench-mark soluble small molecule 2,8-difluoro-5,11-6 
bis(triethylsilylethynyl)anthradithiophene (diF-TES-ADT) and an insulating polymer 7 
polystyrene (PS) enables to overcome previous limitations of EGOFETs and open the way to 8 
its application for bioelectric recordings (Zhang et al., 2016). The strategy of using the organic 9 
blend of an organic semiconductor with PS has been shown to promote material processability 10 
and also leads to thin films with an enhanced crystallinity and environmental stability (Del 11 
Pozo et al., 2016; Temiño et al., 2016). With the aim to employ these organic blend EGOFETs 12 
as bioelectronic recording platform, here we demonstrate the capability of EGOFETs based on 13 
a solution processed organic material diF-TES-ADT blended with polystyrene PS to record the 14 
extracellular action potentials of human Pluripotent Stem Cells derived cardiomyocyte cells 15 
(hPSCs CMs). hPSCs CMs represent a promising and powerful tool in cardiac biology for 16 
cardiac disease modelling. This cellular platform was recently exploited for the generation of 17 
hPSCs-derived cardiac grafts to screen the effect of drugs on human atrial and ventricular 18 
electrophysiology (Garreta et al., 2016). We demonstrate that the electrical activity of the 19 
cultured cells plated on an EGOFET array can be recorded for several days with extreme 20 
stability. Compared to the state of the art EGOFETs reported so far, our device shows a 21 
remarkable stability in physiological conditions with a charge carrier mobility decrease almost 22 
negligible (less than 1 order of magnitude) and with a shift in threshold voltage below 0.1V. In 23 
addition, we also show the possibility to perform cytotoxicity tests of different pharmaceutical 24 
drugs, such as norepinephrine and verapamil, on these devices. We note that the use of 25 
EGOFETs to monitor the electrical activity of hPSCs derived cardiomyocytes can offer an 26 
excellent in vitro platform to cardiac disease modelling, cardiac toxicology and regeneration.  27 
2. Materials and methods 28 
2.1 Device fabrication 29 
A semi-transparent biocompatible Kapton foil (Kapton® HN from DuPont, 75 µm thick) was 30 
used as substrate for our devices; source and drain (S/D) electrodes were defined by maskless 31 
photolithography (MicroWriter ML™ Laser Lithography System) and a metal layer of Cr/Au 32 
(5 nm/40 nm) was subsequently evaporated (System Auto 360 from BOC Edwards). The 33 
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channel width (W) and length (L) were 19680 µm and 30 µm (namely having a geometrical 1 
ratio W/L = 656), respectively. Prior to the deposition of the organic semiconductor, the 2 
substrates were cleaned in ultrasonic bath with acetone and isopropanol for 15 min respectively 3 
and afterward ozone-treated for 25 min. S/D electrodes were subsequently modified by 4 
immersing the device in a 15 mM pentafluorothiophenol  (PFBT) solution in isopropanol for 5 
15 minutes. A blend composed of diF-TES ADT and polystyrene (PS) was chosen as 6 
semiconductor material. The two components were mixed in a 4:1 ratio, and then dissolved in 7 
chlorobenzene reaching a final concentration of 2 wt%. The blend solution was kept on a hot-8 
plate at 105 °C for 1 h to ensure the complete dissolution of the starting materials. Thin film 9 
deposition was realized through Bar-Assisted Meniscus Shearing (BAMS) technique by means 10 
of a home-adapted bar coater working at fixed speed of 1 cm s−1 and at a fixed plate temperature 11 
of 105 °C as reported earlier (Leonardi et al., 2016; Zhang et al., 2016). All the above-12 
mentioned processes were realized under ambient conditions. Prior to cell seeding the devices 13 
were coated with a thin matrigel layer (BD Biosciences) by drop casting. We verified that the 14 
addition of the matrigel layer does not affects severely the device response and it greatly 15 
facilitates cell adhesion. 16 
2.2 Cell Culture 17 
Single cell suspension of human Pluripotent Stem Cells (hPSCs) were seeded onto matrigel 18 
(BD Biosciences) pre-coated cell culture dishes at a density of 125,000 cells per cm2 in mTeSR 19 
medium (StemCell Technologies), supplemented with 5 µM ROCK inhibitor (Y-27632, 20 
Sigma-Aldrich). Cells were then maintained in mTeSR with ROCK inhibitor for 24 h and in 21 
mTeSR only, for one more day. Differentiation was initiated by treatment with 12 µM 22 
CHIR99021 (Selleck) in RPMI (Invitrogen) supplemented with B27 minus insulin (Life 23 
Technologies), 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol, nonessential amino acids and 24 
penicillin-streptomycin (RPMI/B27-insulin medium) for 24 h (day 0 to day 1). On day 1, the 25 
inhibitor was removed by washing with RPMI medium and then maintained in RPMI/B27-26 
insulin medium for two more days. On day 3, cells were treated with 5 µM Wnt inhibitor IWP4 27 
(Stemgent) in RPMI/B27-insulin medium and cultured without medium change for 48 h. On 28 
day 5, cells were washed once with RPMI to eliminate the inhibitor and maintained in RPMI 29 
(Invitrogen) supplemented with B27 (Life Technologies), 2 mM L-glutamine, 0.1 mM 2-30 
mercaptoethanol, nonessential amino acids and penicillin-streptomycin (RPMI/B27 medium). 31 
From day 5, cells were maintained in RPMI/B27 medium with medium change every 2 days.  32 
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On day 14, beating monolayers were obtained. For video recording, hPSC-derived 1 
cardiomyocyte monolayers were imaged at 37ºC in RPMI/B27 medium using a Leica 2 
MC170HD camera connected to a DM IL LED microscope (Leica). Starting from day 20, 3 
clusters of 300-500 beating cells (seeding density is determined based on the surface area to be 4 
occupied by the beating cell) were detached from the plate, seeded on the top of device 5 
transistors, previously coated with matrigel, and further maintained in RPMI/B27 medium 6 
during the course of the recording experiment. The medium was changed every two days during 7 
the course of the experiment. 8 
2.3 Immunocytochemistry 9 
hPSC-derived cardiomyocyte monolayers were fixed with 2% paraformaldehyde (Aname) for 10 
20 min at room temperature. Next, samples were washed twice with PBS and further blocked 11 
and permeabilized for 1 h at room temperature with Tris-buffered saline (TBS) containing 12 
0.5% Triton X100 (Sigma) and 6% donkey serum (Millipore). Samples were then incubated 13 
overnight at 4 °C with primary antibodies. The following primary antibodies were used: 14 
Myosin Heavy Chain (MYH6, GTX20015, 1:100, GeneTex); GATA 4 binding 4 (GATA4, 15 
sc9053, 1:25, Santa Cruz Biotechnology); NKX2.5 (sc8697, 1:25, Santa Cruz Biotechnology); 16 
Troponnin T (TNN, MS-295-P1ABX, 1:500, Thermo Scientific). After the incubation with 17 
primary antibodies, samples were washed three times with TBS containing 0.1% Triton X100 18 
(Sigma) and 6% donkey serum (Millipore) and further incubated for 2 h at room temperature 19 
with fluorescent-conjugated secondary antibodies (Alexa Fluor (A) 488-, Cy3- or A647-; 20 
1:200). After three rinses with PBS, samples were counterstained with 4,6-diamidino-2-21 
phenylindole (DAPI; Life Technologies, 1:5000) for 30 min for the detection of nuclei. 22 
Samples were then mounted using Fluoromount-G (Southern Biotech). Image acquisition was 23 
carried out using a SP5 (Leica) confocal microscope. 24 
2.4 Drugs tested 25 
Norepinephrine Bitartrate salt (C8H11NO3 ·  C4H6O6) and Verapamil hydrochloride 5-[N-(3,4-26 
Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile 27 
hydrochloride were both purchased from Sigma Aldrich. Norepinephrine was dissolved in cell 28 
medium while Verapamil was dissolved in Ethanol. 29 
2.5 EGOFET characterization 30 
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All electrical device characterizations were performed by employing a cell culture media 1 
mTeSR, which is the cell culture medium commonly used for human embryonic stem cells, as 2 
working electrolyte and a Pt wire (Ø = 0.5 mm) as the gate electrode. The measurements were 3 
all carried out inside the incubator under the standard conditions of 37°C temperature, 80% 4 
humidity and 5% CO2.  Agilent B2912A was used as a source measuring unit for the electrical 5 
recording of the transistor. Prior to the recording experiment, typical transistor characterization 6 
of Source-Drain current (ISD) versus Source-Gate voltage (VGS) was carried out. For recording 7 
the extracellular potentials of cardiac cells, the transistor was operated at VGS= - 0.7 V and 8 
VDS=-0.5 V, and the current ISD was monitored over time. The signals were recorded 9 
continuously for a time span of 1000 seconds. Recordings were repeated for at least 3 times a 10 
day. The frequency response of the transistor was measured by using a function generator 11 
33220A Function Waveform Generator (Keysight) coupled to the Agilent B2912A. A 12 
sinusoidal wave oscillation of 10mV was applied to VGS, with the device set at VGS = -0.7 V 13 
and VDS = -0.5 V. 14 
3. Results and Discussion 15 
3.1 Electrical characterisation of the EGOFET in electrophysiological condition 16 
The schematic diagram of the EGOFET with a cluster of cells plated on the channel of the 17 
transistor is depicted in Figure 1(a), while figure 1(b) shows a picture of the actual device and 18 
figure 1(c) a zoom in image with hPSC derived cardiomyocytes plated on top of the transistors 19 
area. The substrate of the device consists of a flexible biocompatible kapton foil onto which 20 
interdigitated gold electrodes 30 nm thick were deposited. The organic semiconductor diF-21 
TES-ADT blended with polystyrene PS was coated onto the substrate using the Bar-Assisted 22 
Meniscus Shearing technique (BAMS) as reported earlier (Leonardi et al., 2016; Zhang et al., 23 
2016). In addition, the device used here was coated with matrigel to favour the adhesion of the 24 
cells to the semiconductor layer. We verified that the presence of the matrigel layer does not 25 
degrade appreciably the performance of the device (Figure S1). The electrical characteristics 26 
of this EGOFET, before cell plating, is depicted in figure 1d. In this case, cell medium mTeSR 27 
was used as working electrolyte. A Source-Gate Voltage VGS is applied between the gate 28 
electrode (Pt wire) immersed in the liquid (see figure 1(b)) and the source electrode, at fixed 29 
source-drain voltage, VDS. The application of a gate potential promotes the formation of a 30 
double layer at the interface between the electrolyte and the organic semiconductor. Since our 31 
active organic material forming the channel of the transistor is a p-type semiconductor, the 32 
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application of a negative potential results in the accumulation of positive charges (holes) on 1 
the semiconductor. When a potential is applied across the Source and Drain electrodes VDS, 2 
charges move across the channel giving rise to the source drain current IDS, whose intensity 3 
depends on the source gate voltage, VGS as shown in figure 1(d).  4 
 5 
Figure 1. (a) Schematic diagram of the EGOFET coupled to hPSCs-CMs grown as a cluster 6 
of cells. (b) Photograph of the experimental setup for extracellular recording. (c) Optical 7 
microscopy image of hPSCs-CMs on the EGOFET (d) Typical Source-Drain current IDS 8 
characteristics versus Gate-Source Voltage VGS of the transistor operated in cell medium, for 9 
VDS=-0.5V. Arrows indicate the forward and reverse scan of the IV curve.  10 
 11 
For extracellular recordings, the main EGOFETs parameters that must be taken into account 12 
are the potentiometric sensitivity, the time response and, most importantly, the stability during 13 
the course of the recording experiment. In order to determine the potentiometric sensitivity, we 14 
applied a constant gate and drain voltage (VGS = -0.7V and VDS=-0.5V) and monitored the 15 
changes in source drain current ∆ISD in response to the application of voltage pulses to the gate 16 
of amplitude ∆VGS, as shown in Figure 2a. We have verified that the transistor is sensitive to 17 
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gate voltages changes down to 20µV. This implies that the device can transduce extracellular 1 
potentials at least down to 20 µV. To gain further insight into the performance of the 2 
EGOFETs, a frequency response characterization of the device was carried out by measuring 3 
the transconductance of the transistor. Fixing VDS at -0.5 V and VGS at -0.7 V, a 10mV peak-4 
to-peak sine wave oscillation was applied on the VGS. A cut-off frequency of ≈ 3 KHz is 5 
obtained for our EGOFETs (Figure 2b). Finally, the stability of the devices in physiological 6 
condition was investigated by monitoring the characteristics of the EGOFET with cell medium 7 
as an electrolyte inside a cell incubator periodically. Figure 2 (c) is a control experiment without 8 
cells where we study the stability of our EGOFETs as a function of time in physiological 9 
condition. The devices were operated using the cell medium as an electrolyte and were placed 10 
inside the incubator under the conditions of temperature of 37 °C, humidity 90%, 5% CO2. This 11 
study represents a key point of our work because organic electronic devices are in general 12 
considered very sensitive to environmental factors. Factors such as temperature, humidity and 13 
a poor electrical instability in “complex” electrolyte such as the cell medium can hinder their 14 
application in bioelectronics. However, one of the main points of this work relies on the 15 
demonstration of the superior robustness of our EGOFETs that is proved with the control 16 
experiment reported in Figure 2 (c) where no electrical failures are observed after 3 weeks in 17 
electrophysiological condition. In order to further demonstrate the robustness of our device, 18 
two important figures of merit, i.e. transconductance gm and threshold voltage Vth, has been 19 




Figure 2 (a) Potentiometric sensitivity of the EGOFETs used in this study. Black and red lines 2 
correspond to the modulation of IDS due to VGS square pulses of amplitudes 100 µV and 20 µV, 3 
respectively. Measurements are recorded in cell medium at VDS = −0.5 V. (b) Frequency 4 
response of the transconductance of the EGOFETs at VGS = −0.7 V and VDS =-0.5 V. (c) 5 
Source-Drain current IDS characteristics versus Gate-Source Voltage VGS of the transistor 6 
operated in cell medium taken for several days. The EGOFET was kept with the electrolyte in 7 
the incubator for several weeks. 8 
 9 
3.2: Electrical recording of cardiomyocyte cells 10 
To demonstrate the capability of these devices to record extracellular bioelectronic signals, 11 
hPSCs-CMs that exhibit spontaneous beating phenomena (Supplementary information video 12 
11 
 
S1) were plated on the EGOFETs (Supplementary information video S2). hPSCs-CMs were 1 
grown as monolayer cell cultures and further transferred on the device upon differentiation 2 
(from day 12 during the protocol of differentiation) (Garreta et al., 2016). hPSC-CMs 3 
monolayers showed the expression of major proteins associated with cardiac muscle 4 
contraction including Troponin T (TNN) and Myosin Heavy Chain (MYH6), as well as nuclear 5 
transcription factors related to cardiac fate such as NK2 Homeobox 5 (NKX2.5) and GATA 6 
binding protein 4 (GATA4) as determined by immunofluorescence analysis (Supplementary 7 
Figure S2 (a) and S2 (b)). For recording the cardiac action potential, EGOFETs were operated 8 
at VGS=-0.7 V and VDS=-0.5 V, and the Source Drain current ISD was monitored as a function 9 
of time. It normally took 5-7 days for the cluster of cells to adequately couple to the EGOFET 10 
channel to generate high electrical signals as also observed in previous reports (Gu et al., 2019). 11 
After a good coupling was achieved and a regular beating of the plated cells was observed (see 12 
video in the supplementary information) spikes on the ISD were easily detected (figure 3(a), 13 
black trace). The recordings were taken continuously for at least 1000 seconds, with a signal 14 
to noise ratio of the recordings between 3-4 which is comparable to the ones measured using 15 
OECTs (Liang et al., 2018; Susloparova et al., 2016; Yao et al., 2015).  A fast Fourier transform 16 
of the time trace (figure 3(b)) showed that the frequency of the spikes was ~ 0.65 Hz, which 17 
nicely agrees with the frequency of contractions observed with the optical microscope. Taking 18 
into account the transconductance of the EGOFET, gm=20 nA/mV, the gate voltage variation 19 
caused by the extracellular potential spike was calculated to be ∆VGS=∆ISD/gm= 40µV, well 20 
within the limit of detection of our device, as demonstrated earlier in figure 2(a). We remark 21 
that each device contains three transistors (see figures 1(c) and S3), and current spikes were 22 
only observed for transistors with cells positioned directly on top of the channel (dark pink 23 




Figure 3 (a). Representative electrical recordings performed with the EGOFET device on 2 
hPSC derived cardiac cells under different conditions. The time traces are presented as 3 
equivalent gate voltage variations obtained from source drain current variations as 4 
∆VGS=∆ISD/gm. The dark pink curve depicts the electrical recording of an EGOEFT in the 5 
absence of cells. The black curve corresponds to basal medium; the red curve to basal medium 6 
with the addition of a 100µM of Norepinephrine; the green curve to basal medium again after 7 
the drug is wash out; and the blue curve to basal medium when 100µM of Verapamil drug is 8 
added. (b) Fast Fourier transform of the time traces shown in (a) for the different conditions. 9 
The circle shows the peak of the first harmonic used to identify the characteristic frequency of 10 
the time traces. (c) Representative shape of the extracellular potentials corresponding to the 11 
average of n = 40 spikes.  12 
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3.3: Pharmacology test 1 
In order to take advantage of this platform we further assessed the effect of two well-known 2 
chronotropic agents, namely norepinephrine and verapamil. First, to modulate the frequency of 3 
the beating rate of the cardiac cells, 100 µM of norepinephrine were added. Norepinephrine is 4 
a widely used cardio stimulant agent known to increase the beating rate of cardiac cells. The 5 
frequency of the spikes recorded after the addition of the drug indeed increased up to 1.3 Hz 6 
(figures 3(a) and 3(b), red lines), which is twice faster than the frequency observed in basal cell 7 
medium. This observation is in accordance with previous investigation on the effect of 8 
Norepinephrine on hPSC-CMs (Huang et al., 2017). After the electrical recording, 9 
norepinephrine drug was washed out. The cells were rinsed with PBS solution and the basal 10 
cell medium was added again. The frequency of the electrical signal recorded following the 11 
washing out of the drug recovered back to 0.8 Hz, which is closer to the pre-drug recording 12 
(figures 3(a) and 3(b) green lines). We also took advantage of verapamil, a drug acting as 13 
blocker of calcium channels. Towards this end, 100 µM of Verapamil was added to the cell 14 
culture. Accordingly, no electrical spikes higher than the instrumental noise level were detected 15 
(figures 3(a) and 3(b), blue lines). 16 
Importantly, we were able to show that the shape of the recorded spikes was quite reproducible. 17 
In this regard, Figure 3(c) shows the average shape of the spikes obtained from the average of 18 
40 spikes for the different conditions examined. The shapes do not display the expected shape 19 
of extracellular potentials corresponding to single cardiomyocytes. The reason can be due to 20 
the complex 3D nature of the cluster of cells and its coupling with the EGOFETs. Further work 21 
becomes necessary to clarify this point. 22 
3.4 : Stability of the EGOFETs in physiological condition 23 
One of the more relevant results obtained with these EGOFETs refers to its remarkable stability 24 
in physiological operation as seen in figure 2 (c). It is well known that organic transistors 25 
generally show instabilities in the presence of humidity, temperature and water (Bobbert et al., 26 
2012). However, the performance of the transistors used in the present study the performance 27 
of the transistors used in the present study seem to be unaltered. Figure 4a shows the I-V 28 
(source-drain current versus source-gate voltage) curves which were recorded during the whole 29 
experimental duration (10 days) to check the lifetime of the device. I-V curves are figures of 30 
merit of a field effect transistor, which include information about the quality of the device. 31 
Such characterization is essential for the complete understanding of the electrical behaviour of 32 





Figure 4. (a) Typical transistor IV curves recorded during the whole study. The legend 2 
describes the day when the IV curve is recorded, and which drug has been added to the cell 3 
medium. Day 1 corresponds to the first day when the cell is seeded on the device. (b) Charge 4 
carrier mobility µ as a function of time in days on the left y axis (black square markers) and 5 
Threshold Voltage VTH as a function of time in days on the right blue axis x (square blues 6 
markers). (c) Representative electrical recording taken on different days, showing the stability 7 
of the device over several days. 8 
 As can be seen, after 10 days with cells, the transconductance of the transistor does not 9 
decrease significantly. The superior performance of these EGOFETs is attributed to the high 10 
crystallinity of the active thin film which has been deposited through a solution shearing 11 
technique, i.e. BAMS, starting from a precursor ink of diF-TES-ADT and polystyrene (Del 12 
Pozo et al., 2016; Leonardi et al., 2016). Furthermore, in the present case, the I-V characteristics 13 
are also good indicators of the status of the transistor in response to drugs such as 14 
norepinephrine and verapamil. The EGOFETs stability is reflected in the fact that the charge 15 
carrier mobility decrease is almost negligible and the shift in threshold is below 0.1V during 16 
days of operation (see figure 4(b) that depicts the change in µ and Vth as a function of days). 17 
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where W and L are the width and length of the channel and CDL is the capacitance of the double 20 
layer. We illustrate the stability of the devices by showing also recorded traces corresponding 21 
to days 6, 8 and 10. As can been seen, the signal to noise ratio did not decrease as a function 22 
15 
 
of days. The outstanding stability of these devices allow us not only to carry out extracellular 1 
recording for over 10 days but also to study the effect of drugs on the bioelectrical activity of 2 
the cardiac cells. We have further checked the electrical performance of an operating transistor 3 
in physiological conditions for a month’s time and, as can be seen from Figure 2c, the EGOFET 4 
still shows excellent performance without any relevant drop in the current.  5 
We have demonstrated that EGOFETs based on a blend of the organic semiconductor diF-TES-6 
ADT with polystyrene can provide stable extracellular electric potential recordings on 7 
electrically excitable cells such as hPSC-CMs. As compared to previous works using 8 
EGOFETs, our device shows a much higher stability when operated in physiological 9 
conditions. The stability of our devices is attributed to the high crystallinity and smoothness of 10 
the films deposited by the shearing technique BAMS (Campos et al., 2018; Pérez-Rodríguez 11 
et al., 2018). The stability of these EGOFETs is reflected in the minimal change of the 12 
transconductance of the transistor during operation in physiological conditions over time. As 13 
an application of these EGOFETs we have considered the study of the electrical activity on 14 
cardiomyocyte-like cells derived from hPSCs under different experimental conditions. Our 15 
experimental setting resulted in further culture of hPSCs-CMs beating monolayers as cluster 16 
of cells forming stable interfaces with these organic devices. Thus, this study proves feasibility 17 
when envisioning the use of EGOFETs for the performance of long-time studies using 18 
electrically excitable cells. It is well accepted that the use of hPSCs and their differentiated cell 19 
types (as cardiomyocytes) offer an unprecedented platform for the study of human disease. In 20 
this regard the possibility to monitor the electrophysiological activity of hPSC-CMs represents 21 
a straightforward approach in further applications related to cardiac drug toxicity and cardiac 22 
disease modelling taking advantage for the combination of this cells together with EGOFETs. 23 
Of note, the long-term stability of the blend based EGOFET-hPSCs cardiac cell platform would 24 
offer a plethora of opportunities to further analyse all these questions and increase our 25 
armamentarium of technologies when envisioning hPSCs-CMs as major cell sources for 26 
understanding cardiac cell biology, cardiac development or disease. 27 
4. Conclusions 28 
To conclude, this work proves unambiguously that small molecule based EGOFETs can be 29 
used as a recording platform to measure the bioelectrical response of excitable cells. Its 30 
operation in accumulation mode with relatively lower charge densities and power consumption 31 
makes it a valid alternative to the commonly used PEDOT PSS based OECTs. EGOFETs 32 
16 
 
employed in this work are based on an organic blend of diF-TES-ADT and Polystyrene which 1 
can be easily processing by a printing technique. The functionality of these devices remains 2 
unaltered when an extracellular matrix such as Matrigel commonly used for attaching cells is 3 
coated on top of the transistor, and when the devices is maintained in physiological conditions 4 
over weeks. Their ability to sense potential changes down to 20 µV at timescales of few 5 
millivolt makes them promising candidate for sensing bioelectrical signals. In this work, we 6 
record the bioelectrical signal of spontaneously beating embryonic cardiomyocyte cells which 7 
couple to the transistor channel. Cardiac action potential of 40 µV are recorded at a frequency 8 
of 0.65 Hz corresponding to the frequency of the beating / contraction of the cardiac cells. The 9 
effect of pharmaceutical drugs such as Norepinephrine and Verapamil on the electrical activity 10 
of the cardiac cells was also successfully demonstrated by using these devices. The stability of 11 
these EGOFETs when operated in physiological environment outstands the state of the art 12 
EGOFET. The stability, high sensitivity and simple architecture of these devices could be 13 
exploited in several directions, including the realization of in vitro fundamental studies on 14 
electrical active cell differentiation and maturation or the development of implantable devices 15 
to monitor bioelectric signals in vivo.   16 
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